Profile picture

Doctor Martin Berger

RWTH University Hospital Aachen, Aachen (Germany)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Complement Factor D is an independent prognostic marker in patients with chronic kidney disease in the UK-Biobank
Presentation
Complement Factor D is an independent prognostic marker in patients with chronic kidney disease in the UK-Biobank
Prolonged fibrinolysis time is a risk factor for mortality in patients with chronic kidney disease  - a propensity score matched analysis
Presentation
Prolonged fibrinolysis time is a risk factor for mortality in patients with chronic kidney disease - a propensity score matched analysis
Clinical implications and risk factors for QRS width progression in heart failure patients
Presentation
Clinical implications and risk factors for QRS width progression in heart failure patients
Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study
Presentation
Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study
Platelet complement C3 deposition predicts platelet hyperactivity in patients with type II diabetes
Presentation
Platelet complement C3 deposition predicts platelet hyperactivity in patients with type II diabetes
Dyslipidemia associated oxidised ldl induces platelet hyperactivity through a cd36-dependent activation of pde3a
Presentation
Dyslipidemia associated oxidised ldl induces platelet hyperactivity through a cd36-dependent activation of pde3a
Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by  CD36 and PLC gamma 2 dependent ROS production
Presentation
Hyperlipidaemia associated oxidised phospholipids induce sustained platelet hyperactivity by CD36 and PLC gamma 2 dependent ROS production

ESC 365 is supported by